Log in  First Connection?

Oncology ImagingArchives

Differentiating the differentiation degree of gastric cancer based on MRI radiomics

 Published on 23/01/2026 |  Original article (Full-text)  | Wang Yilin et al. | BMC Medical Imaging 2025; 26(1): 25

Gastric cancer is the fifth most common tumor with third mortality in the world. In recent decades, the incidence and mortality of gastric cancer have declined. However, due to the population growth in areas with high incidence and the improvement of diagnosis level in relevant areas, the prevalence...

Tumor shrinkage patterns and optimal timing of response assessment during neoadjuvant therapy for breast cancer: a study based on multiparametric MRI

 Published on 16/01/2026 |  Original article (Full-text)  | Wang Jingbo et al. | Cancer imaging 2025; 26(1): 2

Breast cancer is one of the most common malignancies among women. As an important therapeutic strategy, neoadjuvant systemic therapy (NST) has been widely applied in patients with locally advanced breast cancer and certain high-risk molecular subtypes [1, 2]. The primary goal of NST is to downstage the...

Application value of radiomics features based on PSMA PET/CT in diagnosis of clinically significant prostate cancer: a comparison between manual and automatic segmentation

 Published on 09/01/2026 |  Original article (Full-text)  | Geng Yujun et al. | BMC Medical Imaging 2025; 25(1): 528

Prostate cancer is the second most common cancer in men worldwide, with approximately 1.9 million new cases and over 800,000 deaths annually, highlighting the urgent need for accurate early diagnosis and risk stratification [1]. In recent years, positron emission tomography/computed tomography (PET/CT)...

Global trends and academic landscapes of ultrasound applications in lung cancer research: a bibliometric analysis (2000–2024)

 Published on 02/01/2026 |  Original article (Full-text)  | Huang Qiang et al. | Cancer imaging 2025; 25(1): 136

Lung cancer remains the leading cause of cancer-related deaths worldwide, with approximately 2.2 million new cases and 1.8 million deaths annually [1]. Despite advances in diagnostic and therapeutic approaches, significant challenges remain in early detection, accurate staging, and personalized...